It has been known for many years that there is antibody activity in the secretions of the gastrointestinal tract, and there is some evidence that the antibo( ies protect against intestinal infection. Davies (1922) showed specific antibody in stools of patients with dysentery and the studies of Burrows and Havens (1948) showed that gut antibody conferred protection against experimental enteric infection whereas protection correlated poorly with serum antibody titres. Human colostrum has also been shown to contain antibody activity (Sabin and Fieldsteel, 1962; Adinolphi, Glynn, Lindsay, and Milne, 1966; Kenny, Boesman, and Michaels, 1967;  Eddie, Schulkind and Robbins, 1971 ) and this appears to be important in protecting the neonate against enteric infections (Winberg and Wessner, 1971) . IgA antibody is likely to be important in this protective role because it represents a large proportion of the immunoglobulin present in both colostrum and gastrointestinal secretions.
It has also been suggested by Beale, Parish, Douglas, and Hobbs (1971) that a further role of IgA antibody in the gastrointestinal tract could be to block the reaction of IgG or IgM with antigens. Such an action might exist to prevent complementReceived for publication 29 March 1972. fixing reactions which could release substances liable to cause tissue damage in the intestine.
It is therefore important to obtain information about the range of antibody activity in colostrum and gastrointestinal secretions of patients and normal individuals, and this report describes preliminary studies on bacterial agglutination by antibody in colostrum and gastrointestinal secretions. The effect of acid, pepsin, and trypsin on the agglutinating activity has been studied. Because IgA is the predominant class of immunoglobulin in these secretions we have studied purified or semi-purified IgA from these sources. Colostrum was used as the source of IgA for all initial studies because large amounts of highly purified secretory IgA can be prepared from this source, and it was considered important to carry out preliminary studies on the no gastrointestinal disease (3), and normal controls (2). Normal pregnant women cooperated in the provision of colostrum.
Materials and Methods

COLOSTRUM
A standard mechanical breast pump was used to obtain colostrum from normal women one to three days after delivery.
SALIVA
Parotid saliva was collected by use of the Curby cap. In some cases mixed oral saliva was used.
GASTRIC JUICE
Only specimens with a pH above 6.5 at the time of aspiration were used. These were obtained by aspiration through a nasogastric tube positioned fluoroscopically.
JEJUNAL JUICE
Samples were obtained using a double-lumened polythene tube of 4 mm internal diameter with a balloon attached approximately 20 cm from its distal end. The tube was passed under radiological control until the balloon was in the first part of the duodenum. The balloon was then inflated with a dilute solution of Gastrografin which allowed the tube position to be checked accurately. A nasogastric tube was also passed, the stomach was aspirated, and 50 ml of physiological saline containing 20 ,uCi of Cr5' was introduced. Gastric content was withdrawn at 10-minute intervals. The jejunal tube was allowed to siphon freely, and aspirate was collected in 10-minute aliquots. All This was performed using bovine, pure crystalline trypsin (Worthington) . Colostral IgA was diluted to 400 mg/100 ml with 0I15M NaCI and adjusted to pH 8.0 with 0-01M tris HCI buffer to give a final molarity of 0.08M, pH 8.0. In two separate experiments the enzyme-substrate ratios were 1:50 and 1:10 respectively. Subsampling was carried out at intervals from 5 min to 24 hr into an equal volume of lima bean trypsin inhibitor (Koch Light) at pH 7.8. The concentration of trypsin inhibitor in the subsample was sufficient to inhibit twice the concentration of trypsin present. All subsamples were immediately frozen at -260C and later tested for agglutinating activity.
PEPTIC DIGESTION OF IGA
Crystalline pepsin (Worthington) was used. Colostral IgA was diluted to 400 mg/100 ml with isotonic saline. Two separate experiments were performed. In the first experiment, pepsin was used at a concentration c'milar to that found in the normal adult stomach (2 mg/ml) (Reizenstein, 1959) , giving an enzyme-substrate ratio of 1:1, while in the second experiment, the pepsin concentration was chosen to give an enzyme-substrate ratio of 1:100. The pepsin solutions were prepared in 0-02M HCI and aliquots were added to an equal volume of IgA solution giving a final pH of 2.55. These samples were incubated at 370C, and subsamples withdrawn at intervals from 30 sec up to 120 minutes. The subsamples were immediately added to 0-02M NaHCO3, giving a pH of approximately 6.8, and then frozen at -26C and later tested for agglutinating activity (see Table II ).
AGGLUTINATION TESTS
Tube agglutinations were performed by a standard method (Cruickshank, 1965) using live organisms. Tubes were incubated for four hr at 37°C and then overnight at room temperature. All tubes were read using phase contrast illumination. Autoagglutination controls were set up for all tests and any test was discarded if autoagglutination occurred. Agglutination tests were repeated using organisms which had been heated at 1000C for one hour and also in the presence of 2 % D-mannose. In the experiment using an enzyme-substrate ratio of 1:1, pepsin was used at 2 mg/ml, a concentration which simulates the levels found in human gastric juice (Reizenstein, 1959) , all agglutinating activity was lost after 30 seconds' incubation. (11) 9 5 10 10 4 2 6 9 4 6 Proteus (3) 2 1 1 1 1 2 2 2 2 3 Enterobacter ( (Table VII) . This also showed a considerable variation in the organisms agglutinated by individual samples, although the overall total number of the test organisms agglutinated by each sample was similar to that found with gastric juice. Proteus ( (Bull, Bienenstock, and Tomasi, 1971) and there is no reason to believe that the results obtained with one cannot be extrapolated to the other.
SPECIFICITY OF AGGLUTINATION
Previous studies have demonstrated antibacterial antibody in colostrum (Adinolphi et al, 1966; Kenny et al, 1967; Eddie et al, 1971 ) the antibody being largely or entirely IgA. The present work shows that human colostral IgA has agglutinating activity against a wide range of aerobic intestinal organisms, even when tested at concentrations much lower than those found in whole colostrum. Heating the organism for one hr at 100°C altered the agglutinating titres by 1 or 2 dilutions only, and this indicates that antibody to both 0 and K antigens may be involved. Alternatively, a similar finding would be expected if agglutination was due to antibody to A antigens. Fimbrial agglutination was considered to be excluded because autoagglutination did not occur and the agglutination titres were not affected by the presence of 2 % D mannose. The fact that agglutinin activity against one organism could be easily removed from the IgA preparation with no effect on its ability to agglutinate other organisms (Table IV) provided strong evidence that agglutination was due to specific antibody. (These experiments were performedat apH of 4.5 with incubation periods up to four hours.) However, when considering the functions of IgA in the intestine, it may be misleading to assess the effect of acid or enzymes on the IgA molecule merely by measuring the change in total amount of IgA present by a method such as immunodiffusion using specific anti-serum since it is possible that there may be precipitable IgA present which has lost its antigenbinding ability. This is strongly suggested by some of our data. For example, in Table VI the samples from patients 2 and 5 show very little antibody activity against certain organisms despite the fact that IgA was readily detected by immunodiffusion. Both these patients were acid secretors in whom neutral basal samples were tested.
There have been few studies on the effect of acid and enzymic digestion on the function of secretory IgA antibody. Steward (1971) examined the effect of trypsin digestion on the ability of rabbit secretory IgA to bind '25Lodine-labelled albumin and demonstrated that trypsin, although producing partial degradation of IgA to 5S fragments, had little effect on its antigen-binding activity. Kenny et al (1967) found that haemagglutinins in whole human milk were destroyed bypH 2 in 10 to 20 minutes, and that peptic digestion had little effect when carried out at pH 4. The work reported here indicates that colostral IgA agglutinins are markedly resistant to trypsin and acid, although relatively sensitive to pepsin at concentrations found in normal adult gastric juice. We feel that the lower pH used in our experiments more closely resembles the conditions to which IgA might be subjected in the adult stomach. The neonatal stomach, however, has very little proteolytic activity in the first 20-30 days of life, even when the gastriccontent is tested at pH 2 (Agunod,Yamaguchi, Lopez, Luhby, and Jerzy Glass, 1969) . Our evidence therefore, supports the view that colostral secretory IgA retains its antibody activity in the neonatal gut.
In the adult, our data suggest that small intestinal fluid should contain undegraded IgA even if precautions are not taken to neutralize trypticactivity, but that in the normal acid stomach IgA will not be detectable, and this is in agreement with published findings (Douglas, Crabbe, and Hobbs, 1970; McClelland, Finlayson, Samson, Nairn, and Shearman, 1971 The development of intestinal antibody has been studied in response to bacterial antigens (Eddie et al, 1971 ) and viruses (Ogra, Karzon, Righthand, and MacGillivray, 1968; Ogra and Karzon, 1969) . We have studied the pattern of antibody to live common intestinal organisms in patients in whom no attempt has been made to induce a response. Thus the results reported give some idea of the normal range of IgA agglutin inactivity in response to common intestinal organisms. No attempt has been made to relate the antibody activity in a given individual to his own flora. The finding of this range of activity in intestinal samples supports the view that the normal production of antibacterial antibody may have a role in the homeostasis of the gut flora. In hypogammaglobulinaemia the pattern of colonization of the intestine may be abnormal even though the total numbers of organisms may not be significantly different from the numbers in control patients (Parkin, McClelland, O'Moore, PercyRobb, Grant, and Shearman, 1972) .
The exact function of agglutinating antibody to bacteria in the gut is not yet clear. There is one report (Adinolphi et al, 1966) of complementdependent bactericidal activity in colostral IgA, but this has not been confirmed, and bactericidal action of IgA has not been shown by other workers. A limited amount of work indicates that lgA is effective in opsonization (Shklair, Rovelstad, and Lamberts, 1969; Wernet, Breu, Knop, and Rowley, 1971 (1969) it also seems unlikely that stimulation of one site in the gut by bacterial flora would engender production of antibody at another site. A more likely explanation for the similar antibody activity in the stomach and jejunum is that both sites are being stimulated by a similar bacterial flora and it has been shown (Dellipiani and Girdwood, 1964; Gray and Shiner, group.bmj.com on October 21, 2017 -Published by http://gut.bmj.com/ Downloaded from 1967) that gastric and jejunal flora are similar in achilorhydric patients. Of the individuals showing no correlation between gastric and jejunal samples, one was a normal volunteer and the other had IgG myeloma. The relative lack of correlation of salivary agglutinins with those in the jejunum in some patients would be entirely in keeping with the widely different bacterial flora of the mouth.
It has been postulated by Beale et al (1971) that defects in the production of IgA antibody could lead to complement-fixing reactions between gut antigens and IgG or IgM which might produce harmful effects. These mechanisms are emphasized by the observation of Eddie et al (1971) that the combination of an IgA antibody with Salmonella typhimurium inhibits the complement-dependent bactericidal effect of IgG or IgM antibodies on that organism. The significance of these observations in relation to infective and inflammatory bowel disease needs further exploration but the methods described here should enable antibody function to be assessed in gastrointestinal disorders. 
